Advanced Biomed is trading 5.02% higher at $6.70, with broad biotech-sector momentum the most likely explanation for the move.
- Shares opened materially higher than the September 22 close of $6.38.
- XBI gained about 2.07% during regular trading.
- No reliable company-specific announcement, filing, earnings update, or analyst action was identified for September 23, 2026; available company-news listings showed earlier announcements but no fresh catalyst matching the move.